Intercept to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 05 2021 - 08:00AM
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases, today
announced that Jerry Durso, President and Chief Executive Officer
of Intercept, will present at the 39th Annual J.P. Morgan Virtual
Healthcare Conference on Thursday, January 14, 2021 at 11:40 a.m.
ET.
A live webcast of the event will be available on the investor
page of Intercept’s website at http://ir.interceptpharma.com. An
audio archive of the webcast will also be available on Intercept’s
website for approximately two weeks.
About InterceptIntercept is a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases,
including primary biliary cholangitis (PBC) and nonalcoholic
steatohepatitis (NASH). Founded in 2002 in New York, Intercept has
operations in the United States, Europe and Canada. For more
information, please visit www.interceptpharma.com or connect with
the company on Twitter and LinkedIn.
CONTACT
For more information about Intercept, please contact:
Investor inquiries:
investors@interceptpharma.com
Media inquiries: media@interceptpharma.com
Source: Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Feb 2024 to Mar 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Mar 2023 to Mar 2024